360 related articles for article (PubMed ID: 21940538)
1. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
3. The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.
Shimizu R; Tamai H; Mori Y; Shingaki N; Maeshima S; Nuta J; Maeda Y; Moribata K; Muraki Y; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Hepatol Int; 2016 Mar; 10(2):328-39. PubMed ID: 26530813
[TBL] [Abstract][Full Text] [Related]
4. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
5. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma.
Motoyama T; Ogasawara S; Chiba T; Higashide T; Yokota H; Kanogawa N; Suzuki E; Ooka Y; Tawada A; Irie R; Ochi S; Masuda Y; Uno T; Yokosuka O
Abdom Imaging; 2014 Apr; 39(2):262-8. PubMed ID: 24346490
[TBL] [Abstract][Full Text] [Related]
6. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
8. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
9. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation.
Maruyama H; Takahashi M; Shimada T; Sekimoto T; Kamesaki H; Kanai F; Yokosuka O
AJR Am J Roentgenol; 2013 Mar; 200(3):570-7. PubMed ID: 23436846
[TBL] [Abstract][Full Text] [Related]
12. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
Park Y; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments.
Santambrogio R; Costa M; Strada D; Bertolini E; Zuin M; Barabino M; Opocher E
Ultrasound Med Biol; 2011 Jan; 37(1):7-15. PubMed ID: 21084155
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation.
Chung HA; Kim JH; Hwang Y; Choi HS; Ko SY; Choe WH; Kwon SY
Saudi J Gastroenterol; 2016; 22(1):57-63. PubMed ID: 26831608
[TBL] [Abstract][Full Text] [Related]
15. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.
Chopra S; Dodd GD; Chintapalli KN; Leyendecker JR; Karahan OI; Rhim H
AJR Am J Roentgenol; 2001 Aug; 177(2):381-7. PubMed ID: 11461868
[TBL] [Abstract][Full Text] [Related]
16. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
[TBL] [Abstract][Full Text] [Related]
18. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
Kim JS; Kim W; So YH; Yu SJ; Kim BG
J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications.
Laspas F; Sotiropoulou E; Mylona S; Manataki A; Tsagouli P; Tsangaridou I; Thanos L
J Gastrointestin Liver Dis; 2009 Sep; 18(3):323-8. PubMed ID: 19795027
[TBL] [Abstract][Full Text] [Related]
20. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]